Register Login

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Abstract

This Commentary article discusses the safety and effectiveness of intraoperative cell salvage in cancer surgery. Modern techniques, such as leukocyte reduction filters and monoclonal antibodies like Catumaxomab, have been developed to minimize this risk by removing tumor cells from salvaged blood. Ongoing studies aims to assess the safety of re-infusing filtered blood, potentially improving patient outcomes during cancer surgeries​.

Downloads

pdf
Authors

Suma Choorapoikayil - Goethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain Therapy, Frankfurt, Germany

Kai Zacharowski - Goethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain Therapy, Frankfurt, Germany

Patrick Meybohm - University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Würzburg, Germany

  • Abstract viewed - 85 times
  • pdf downloaded - 53 times